Cargando…

Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report

BACKROUND: We describe one of the first cases of a Posterior reversible encephalopathy syndrome (PRES) under tocilizumab as treatment of Giant cell arteritis (GCA). CASE PRESENTATION: A 65-year-old female with known GCA and treatment with Tocilizumab (TCZ) developed a convulsive epileptic seizure fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butryn, Michaela, Mewes, Sabine, Feist, Eugen, Beuing, Oliver, Müller, Christian, Neumann, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218423/ https://www.ncbi.nlm.nih.gov/pubmed/34157987 http://dx.doi.org/10.1186/s12883-021-02231-7

Ejemplares similares

Unusual presentation of Takayasu's arteritis as posterior reversible encephalopathy syndrome
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Posterior reversible encephalopathy syndrome caused by presumed Takayasu arteritis
por: Lee, Ki Wuk, et al.
Publicado: (2016)

Posterior Reversible Encephalopathy Syndrome: An Atypical Presentation of Takayasu Arteritis
por: Ranjan, Abhay, et al.
Publicado: (2022)

Atypical Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Polymyalgia Rheumatica and Giant Cell Arteritis
por: FALSETTI, PAOLO, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome with Lilliputian hallucinations secondary to Takayasu's arteritis
por: Dunne, R.M., et al.
Publicado: (2020)

Posterior reversible encephalopathy syndrome revealing Takayasu's arteritis in a child
por: Jadib, Abdelhamid, et al.
Publicado: (2021)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018)

Vision loss in patients with giant cell arteritis treated with tocilizumab
por: Amsler, Jennifer, et al.
Publicado: (2021)

Giant Cell Arteritis With Chronic Bronchitis Successfully Treated With Tocilizumab
por: Ohta, Ryuichi, et al.
Publicado: (2023)

Tocilizumab: Posterior reversible encephalopathy syndrome following off-label treatment: 4 case reports
Publicado: (2021)

Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
por: Seitz, Luca, et al.
Publicado: (2021)

Tocilizumab for relapsing and remitting giant cell arteritis: a case series
por: Saha, Pratyasha, et al.
Publicado: (2022)

Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab
por: Talluri, Krishna, et al.
Publicado: (2021)

CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis
por: Pawlitzki, Marc, et al.
Publicado: (2019)

Posterior reversible encephalopathy syndrome
por: Fischer, Marlene, et al.
Publicado: (2017)

Posterior Reversible Encephalopathy Syndrome
por: Gewirtz, Alexandra N., et al.
Publicado: (2021)

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2021)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab
por: Hara, Kazusato, et al.
Publicado: (2021)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

55. A case for continuing tocilizumab beyond 12 months in giant cell arteritis?
por: Ming, Caroline, et al.
Publicado: (2019)

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
por: Loricera, Javier, et al.
Publicado: (2022)

Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis
por: Matza, Mark A, et al.
Publicado: (2023)

Posterior reversible encephalopathy syndrome postpartum
por: Nielsen, Lise Hald, et al.
Publicado: (2015)

Posterior Reversible Encephalopathy Syndrome in ALL
por: Millichap, J. Gordon
Publicado: (2015)

Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017)

Brainstem Posterior Reversible Encephalopathy Syndrome
por: Hama, Ryosuke, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020)

Malignant Posterior Reversible Encephalopathy Syndrome: A Case of Posterior Irreversible Encephalopathy Syndrome
por: Martins, William Alves, et al.
Publicado: (2016)

Stevens Johnson Syndrome in a Patient with Giant Cell Arteritis During Short Term Tocilizumab Therapy
por: Venkateswaran, Niranjani, et al.
Publicado: (2020)

Positive Effect of Steroids in Posterior Reversible Encephalopathy Syndrome
por: Meyer, Marco, et al.
Publicado: (2019)

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
por: Conticini, Edoardo, et al.
Publicado: (2020)

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
por: de Boysson, Hubert, et al.
Publicado: (2021)

Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report
por: Cho, Young Min, et al.
Publicado: (2023)

Posterior reversible encephalopathy syndrome at term pregnancy
por: Achar, Shreepathi Krishna, et al.
Publicado: (2011)

Posterior reversible encephalopathy syndrome in neuro-malaria
por: Lacout, Alexis, et al.
Publicado: (2010)

Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
por: Costa, Ricardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dod43iae2j3h96nai9bpn8lofh